Tirzepatide for Obesity Management We analyzed 12 randomized trials comparing two leading incretin-based therapies: Weight Reduction Retatrutide: 16.3 kg | 23.8% Tirzepatide: 11.8 kg | 16.8% Retatrutide demonstrated greater efficacy in both absolute and percentage weight loss
The GLP-1 receptor belongs to class B of the G-protein-coupled receptors, a subfamily characterized by a large N-terminal extracellular ligand binding domain
Available at: Buonanno S, Gaggiano C, Terribili R, Cantarini L, Frediani B, Gentileschi S
However, alcohol can make side effects such as nausea, dizziness, or indigestion worse, particularly when starting treatment
K., Iliopoulos, O
Given as a single agent, it promotes modest increases in survival, and these effects are enhanced when combined with oxaliplatin and/or irinotecan (FOLFOX, FOLFIRI) 2,3